Rafa Biodefense’s recent participation in the BioJapan 2026 conference in Yokohama provided an opportunity to engage with relevant companies and explore collaboration opportunities, in light of Japan’s emerging preparedness needs.
The threat environment facing countries around the world is complex and evolving. Japan is no exception. Examples driving geopolitical tensions across the Asia-Pacific region include expanding military activities in the East and South China Seas and North Korea’s weapons programs. In recent years, Japan has responded with a significant reassessment of the nation’s defense capabilities, as shown by the Ministry of Defense’s program on transformation. Japan is making significant investments to modernize the Japan Self-Defense Forces and strengthen national resilience. Its fiscal year 2026 defense budget reached approximately ¥9 trillion ($58 billion).
In addition, Japan’s cabinet recently adopted a new plan to address domestic chemical, biological, radiological, nuclear and explosive (CBRNE) threats. The plan establishes a new expert government advisory panel, encourages enhanced intelligence sharing across agencies, and proposes medical system improvements. Importantly, the plan also addresses the need to secure critical medical supplies for CBRNE incidents.
Japan has experienced chemical terrorism in the past, most notably the 1995 Tokyo subway sarin attack, which highlighted the critical importance of rapid medical response and emergency preparedness. The threat landscape evolved significantly over the last 30 years. The risks posed by unmanned drones is of particular concern, and Japan’s military is complementing the domestic CBRN action plan with investments in counter-drone capabilities.
For Rafa Biodefense, drawing on decades of experience in medical countermeasure autoinjectors, BioJapan 2026 provided a valuable opportunity to explore collaborations that could support Japan’s evolving medical preparedness priorities. Effective medical countermeasures, emergency treatment capabilities, and resilient healthcare systems are essential components of any national security strategy. As Japan continues to strengthen its defense capabilities and emergency preparedness, innovative medical technologies will have an important role to play in protecting lives and strengthening national resilience.
